Aristo Bio-Tech — 360° view

Aristo Bio-Tech, a company in the Pesticides & Agrochemicals industry, reported revenue of ₹198 crore and net profit of ₹5.00 crore for the September 2026 quarter.

Aristo Bio-Tech (NSE: ARISTO-SM) closed at ₹123.00 on 20 Nov 2026. Its market capitalisation is ₹84 crore and it trades at 11.7 times earnings.

Share price
₹123.00 (20 Nov 2026)
Market cap
₹84 Cr (20 Nov 2026)
P/E
11.66 (20 Nov 2026)
Revenue
₹198 Cr (September 2026 quarter)
Net profit
₹5 Cr (September 2026 quarter)
ROCE
19.6% (FY26)
ROE
17.6% (FY26)
Book value
₹72.0 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹128.50 / ₹85.00 (20 Nov 2026)
Sector
Commodities
Industry
Pesticides & Agrochemicals
Symbol
NSE: ARISTO-SM

Incorporated in 2005, Aristo Bio-Tech and Lifescience Ltd manufactures and supplies pesticides and agrochemicals

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.